Strata Skin Sciences ROA 2010-2024 | SSKN

Current and historical return on assets (ROA) values for Strata Skin Sciences (SSKN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Strata Skin Sciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-09-30 $-0.01B $0.04B -22.22%
2024-06-30 $-0.01B $0.04B -18.93%
2024-03-31 $-0.01B $0.04B -23.91%
2023-12-31 $-0.01B $0.04B -22.80%
2023-09-30 $-0.01B $0.05B -13.79%
2023-06-30 $-0.01B $0.06B -13.40%
2023-03-31 $-0.01B $0.05B -11.54%
2022-12-31 $-0.01B $0.05B -11.21%
2022-09-30 $-0.01B $0.05B -13.40%
2022-06-30 $-0.01B $0.05B -13.79%
2022-03-31 $-0.00B $0.06B -8.25%
2021-12-31 $-0.00B $0.05B -6.49%
2021-09-30 $-0.00B $0.05B -4.32%
2021-06-30 $-0.00B $0.05B -4.32%
2021-03-31 $-0.01B $0.05B -10.75%
2020-12-31 $-0.00B $0.05B -8.60%
2020-09-30 $-0.01B $0.05B -10.75%
2020-06-30 $-0.01B $0.05B -10.70%
2020-03-31 $-0.00B $0.05B -8.47%
2019-12-31 $-0.00B $0.05B -8.38%
2019-09-30 $-0.00B $0.05B -6.25%
2019-06-30 $-0.00B $0.05B -6.32%
2019-03-31 $-0.00B $0.05B -6.38%
2018-12-31 $-0.00B $0.05B -9.04%
2018-09-30 $-0.01B $0.05B -19.05%
2018-06-30 $-0.02B $0.05B -51.85%
2018-03-31 $-0.02B $0.04B -52.83%
2017-12-31 $-0.02B $0.04B -50.91%
2017-09-30 $-0.02B $0.04B -42.60%
2017-06-30 $-0.01B $0.04B -13.95%
2017-03-31 $-0.01B $0.04B -11.56%
2016-12-31 $-0.00B $0.04B -8.99%
2016-09-30 $-0.00B $0.04B -8.65%
2016-06-30 $-0.01B $0.04B -28.87%
2016-03-31 $-0.02B $0.05B -43.14%
2015-12-31 $-0.03B $0.05B -65.12%
2015-09-30 $-0.03B $0.05B -92.96%
2015-06-30 $-0.02B $0.05B -80.70%
2015-03-31 $-0.01B $0.02B -77.78%
2014-12-31 $-0.02B $0.02B -82.19%
2014-09-30 $-0.01B $0.02B -83.58%
2014-06-30 $-0.02B $0.01B -135.71%
2014-03-31 $-0.03B $0.02B -152.11%
2013-12-31 $-0.03B $0.01B -120.93%
2013-09-30 $-0.03B $0.01B -121.35%
2013-06-30 $-0.03B $0.03B -104.17%
2013-03-31 $-0.02B $0.03B -101.10%
2012-12-31 $-0.02B $0.02B -103.53%
2012-09-30 $-0.02B $0.02B -84.85%
2012-06-30 $-0.02B $0.02B -88.89%
2012-03-31 $-0.02B $0.03B -87.13%
2011-12-31 $-0.02B $0.03B -80.77%
2011-09-30 $-0.02B $0.02B -78.50%
2011-06-30 $-0.02B $0.02B -63.49%
2011-03-31 $-0.02B $0.03B -61.54%
2010-12-31 $-0.02B $0.03B -59.70%
2010-09-30 $-0.02B $0.04B -63.64%
2010-06-30 $-0.02B $0.03B -70.59%
2010-03-31 $-0.02B $0.03B -80.00%
2009-12-31 $-0.02B $0.03B -95.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.013B $0.033B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $9.226B 0.00
Inspire Medical Systems (INSP) United States $5.656B 176.38
Hims & Hers Health (HIMS) United States $5.534B 140.72
Enovis (ENOV) United States $2.608B 17.68
Privia Health (PRVA) United States $2.587B 215.60
IRhythm Technologies (IRTC) United States $2.316B 0.00
Azenta (AZTA) United States $2.209B 110.15
Omnicell (OMCL) United States $2.116B 69.23
10x Genomics (TXG) United States $1.732B 0.00
Clover Health Investments (CLOV) United States $1.689B 0.00
Schrodinger (SDGR) United States $1.518B 0.00
Phreesia (PHR) United States $1.148B 0.00
Butterfly Network (BFLY) United States $0.690B 0.00
Standard BioTools (LAB) United States $0.596B 0.00
Talkspace (TALK) United States $0.583B 0.00
Fulgent Genetics (FLGT) United States $0.547B 0.00
Definitive Healthcare (DH) United States $0.505B 87.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.268B 0.00
TruBridge (TBRG) United States $0.247B 71.91
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
American Well (AMWL) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.112B 0.00
P3 Health Partners (PIII) United States $0.076B 0.00
HeartBeam (BEAT) United States $0.074B 0.00
111 (YI) China $0.052B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.044B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zepp Health (ZEPP) China $0.037B 0.00
Movano (MOVE) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
MSP Recovery (LIFW) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00